Found: 25
Select item for more details and to access through your institution.
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases.
- Published in:
- Drugs, 2023, v. 83, n. 4, p. 299, doi. 10.1007/s40265-023-01840-5
- By:
- Publication type:
- Article
A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6577, doi. 10.3390/jcm12206577
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1813, doi. 10.3390/jcm11071813
- By:
- Publication type:
- Article
Predictors of aggressive inflammatory bowel disease.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Predictors of Aggressive Inflammatory Bowel Disease.
- Published in:
- Gastroenterology & Hepatology, 2011, v. 7, n. 10, p. 652
- By:
- Publication type:
- Article
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 10, p. 3563, doi. 10.1007/s10620-020-06669-6
- By:
- Publication type:
- Article
Better Late than Never: Adding Thiopurines After Loss of Response to Infliximab Monotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.
- Published in:
- Crohn's & Colitis 360, 2022, v. 4, n. 1, p. 1, doi. 10.1093/crocol/otac002
- By:
- Publication type:
- Article
Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile.
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 2, p. 135, doi. 10.20524/aog.2022.0690
- By:
- Publication type:
- Article
Cross-sectional analysis of patient phone calls to an inflammatory bowel disease clinic.
- Published in:
- Annals of Gastroenterology, 2015, v. 28, n. 3, p. 357
- By:
- Publication type:
- Article
Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation.
- Published in:
- Annals of Gastroenterology, 2015, v. 28, n. 3, p. 366
- By:
- Publication type:
- Article
Prevalence of Thyroid Cancer in Multinodular Goiter Versus Single Nodule: A Systematic Review and Meta-Analysis.
- Published in:
- Thyroid, 2013, v. 23, n. 4, p. 449, doi. 10.1089/thy.2012.0156
- By:
- Publication type:
- Article
Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 7, p. 933, doi. 10.1111/apt.13970
- By:
- Publication type:
- Article
Letter: is there a bi-directional relationship between depression and IBD? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 2, p. 214, doi. 10.1111/apt.12819
- By:
- Publication type:
- Article
Letter: psychological remission - a future endpoint in inflammatory bowel disease? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 12, p. 1436, doi. 10.1111/apt.12784
- By:
- Publication type:
- Article
The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 8, p. 802, doi. 10.1111/apt.12669
- By:
- Publication type:
- Article
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 10, p. 1596, doi. 10.1093/ecco-jcc/jjae060
- By:
- Publication type:
- Article
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1270, doi. 10.1093/ecco-jcc/jjae038
- By:
- Publication type:
- Article
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 6, p. 885, doi. 10.1093/ecco-jcc/jjae007
- By:
- Publication type:
- Article
Intestinal Tissue Levels of Anti-Tumour Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases: Are We Looking in The Right Place at The Right Time?
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 869, doi. 10.1093/ecco-jcc/jjab233
- By:
- Publication type:
- Article
Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms.
- Published in:
- Journal of Crohn's & Colitis, 2014, v. 8, n. 6, p. 504, doi. 10.1016/j.crohns.2013.11.003
- By:
- Publication type:
- Article
Response to Raftery and O'Sullivan.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 4, p. 741, doi. 10.1038/ajg.2011.63
- By:
- Publication type:
- Article